In vitro experiments found that up-regulation of APOL6 could promote the necrosis and pyroptosis of pancreatic cancer cells, while necrosis and pyroptosis could enhance anti-tumor immune effects, which also indirectly explained the up-regulation of APOL6 in immunotherapy responders [36]. This evidence concerns the gene APOL6 and familial pancreatic carcinoma.